Arcturus Therapeutics Holdings Inc.
ARCTFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
138
Cost of Revenue
0
Gross Profit
138
Gross Margin
100.0%
Operating Income
-96
Operating Margin
-69.1%
Net Income
-81
Net Margin
-58.5%
EPS (Basic)
$-3.00
EPS (Diluted)
$-3.00
EBITDA
-77
EBITDA Margin
-55.9%
2023
12/31/2023
Revenue
158
Cost of Revenue
0
Gross Profit
158
Gross Margin
100.0%
Operating Income
-78
Operating Margin
-49.6%
Net Income
-30
Net Margin
-18.8%
EPS (Basic)
$-1.12
EPS (Diluted)
$-1.12
EBITDA
-24
EBITDA Margin
-15.3%
2022
12/31/2022
Revenue
206
Cost of Revenue
0
Gross Profit
206
Gross Margin
100.0%
Operating Income
12
Operating Margin
5.9%
Net Income
9
Net Margin
4.5%
EPS (Basic)
$0.35
EPS (Diluted)
$0.35
EBITDA
14
EBITDA Margin
6.7%
2021
12/31/2021
Revenue
12
Cost of Revenue
0
Gross Profit
12
Gross Margin
100.0%
Operating Income
-203
Operating Margin
-1641.3%
Net Income
-204
Net Margin
-1648.0%
EPS (Basic)
$-7.74
EPS (Diluted)
$-7.74
EBITDA
-202
EBITDA Margin
-1631.7%
2020
12/31/2020
Revenue
10
Cost of Revenue
56
Gross Profit
-46
Gross Margin
-486.5%
Operating Income
-72
Operating Margin
-749.8%
Net Income
-72
Net Margin
-756.3%
EPS (Basic)
$-3.55
EPS (Diluted)
$-3.55
EBITDA
-71
EBITDA Margin
-740.6%